Starts: 1/28/2025 |  Expires: 1/28/2027

The Inpatient Diabetes Certificate is a comprehensive program that prepares healthcare professionals to effectively manage diabetes and hyperglycemia in hospitalized patients. It addresses the full continuum of care, from intake to hospitalization and discharge. Learners will develop assessment, intervention, and discharge planning skills to ensure glycemic management throughout the hospital stay.

AACE Inpatient Diabetes Certificate is designed to provide Patient Care Team Members with an introductory and comprehensive online best practices course to help care team members manage and improve patient outcomes with diabetes.

The primary target audience includes Nurse Practitioners, Physician Assistants, and Pharmacists. The secondary target audience includes Endocrinologists and Primary Care Physicians.  

After completing this activity, participants will be able to: 

• Describe the impact of glycemic control on hospitalized patients and identify optimal glucose targets based on current guidelines for critically ill and non-critically ill patients. 
• Assess and implement safe and effective medication strategies, including insulin and other glucose-lowering agents, tailored to the unique requirements of the inpatient setting. 
• Identify and apply appropriate diabetes technologies, such as continuous glucose monitors (CGMs) and insulin pumps, ensuring their safe use, integration, and transition at discharge when necessary. 
• Differentiate between common hyperglycemic crises, including diabetic ketoacidosis (DKA) and hyperosmolar hyperglycemic syndrome (HHS) and manage these emergencies through evidence-based protocols. 
• Develop skills to recognize and promptly manage inpatient hypoglycemia, particularly in patients at higher risk due to specific feeding methods or treatment regimens. 
• Implement patient-centered discharge planning to support continued glycemic control posthospitalization, coordinating with outpatient providers and resources to enhance patient outcomes.  

Physician Credit 

The American College of Endocrinology (ACE) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. 

The American College of Endocrinology (ACE) designates enduring activity for a maximum of 7 AMA PRA Category 1 Credit(s)^TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

Nursing Credit 

Provider approved by the California Board of Registered Nursing, Provider Number 17762, for 7 contact hours. 

The American Association of Clinical Endocrinologists (AACE) remains strongly committed to providing the best available evidence-based clinical information to participants of this educational activity and requires an open disclosure of any potential conflict of interest identified by our faculty members. It is not the intent of AACE to eliminate all situations of potential conflict of interest, but rather to enable those who are working with AACE to recognize situations that may be subject to question by others. All disclosed conflicts of interest are reviewed by the CME Subcommittee to ensure that such situations are properly evaluated and, if necessary, resolved. AACE educational standards pertaining to conflict of interest are intended to maintain the professional autonomy of the clinical experts inherent in promoting a balanced presentation of science. Through our review process, all AACE accredited activities are ensured of independent, objective, scientifically balanced presentations of information. Disclosure of any or no relationships will be made available for all educational activities.   

Planner Disclosures

Planner Name	Ineligible Company	Relevant Financial Relationship
Allyson McNally, NP	Medtronic	Stock Ownership
Archana Sadhu. MD	Abbott	Consultant
Diana Issacs, PhD	Abbott, Dexcom, Medtronic, Insulet, Lilly, Novo Nordisk, Cequr	Speakers Bureau
	Lilly, Sanofi, Medtronic, Lifescan	Consultant
Halis Akturk, MD	Dexcom, Tandem, Senseonics, Medtronic, Eli Lilly, IM Therapeutics, REMD, IAFMS	Research Funding
	Dexcom, Medtronic, Tandem	Consultant

All of the relevant financial relationships listed for these individuals have been mitigated. All other planners for this educational activity have no relevant financial relationships to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling or distributing healthcare products used by or on patients. 

Faculty Disclosures

Faculty Name	Ineligible Company	Relevant Financial Relationship
Archana Sadhu, MD	Abbott	Consultant

All of the relevant financial relationships listed for these individuals have been mitigated. All other faculty for this educational activity have no relevant financial relationships to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. 

Reviewers 

None of the reviewers for this educational activity have relevant financial relationships to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling or distributing healthcare products used by or on patients.